glp 1 agonist liraglutide GLP-1 Agonists: Semaglutide & in Diabetes GLP-1 Medications for Weight Loss:

Clinical trials that investigate dual GLP-1/GIP receptor agonists have presented encouraging evidence for their efficacy and safety in treating MASLD

A specific gut microbiota dysbiosis of type 2 diabetic mice induces GLP-1 resistance through an enteric NO-dependent and gut-brain axis mechanism

Interestingly, certain classical inflammatory stimuliincluding lipopolysaccharide (LPS) and pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor- (TNF-) can, in turn, induce GLP-1 secretion

2022 AHA/ACC/HFSA guideline for the management of heart failure: Executive summary: A report of the American college of cardiology/American heart association joint committee on clinical practice guidelines

Journal of Clinical Endocrinology and Metabolism, 103 ,

15 Moreover, the pharmacokinetics of semaglutide are not significantly affected by renal or hepatic impairment, 21,22 and thus, no dose adjustment is required in these populations